Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

1.

Protein C and acute inflammation: a clinical and biological perspective.

Christiaans SC, Wagener BM, Esmon CT, Pittet JF.

Am J Physiol Lung Cell Mol Physiol. 2013 Oct 1;305(7):L455-66. doi: 10.1152/ajplung.00093.2013. Epub 2013 Aug 2. Review.

PMID:
23911436
[PubMed - indexed for MEDLINE]
2.

Human recombinant activated protein C for severe sepsis.

Martí-Carvajal AJ, Solà I, Lathyris D, Cardona AF.

Cochrane Database Syst Rev. 2012 Mar 14;3:CD004388. doi: 10.1002/14651858.CD004388.pub5. Review. Update in: Cochrane Database Syst Rev. 2012;12:CD004388.

PMID:
22419295
[PubMed - indexed for MEDLINE]
3.

[Activated proteine C].

Montravers P, Quintard H, Piednoir P.

Ann Fr Anesth Reanim. 2006 Mar;25(3):270-4. Epub 2006 Jan 4. Review. French.

PMID:
16387470
[PubMed - indexed for MEDLINE]
4.

[Activated protein C (the impact of PROWESS trial)].

Iba T, Kidokoro A.

Nihon Rinsho. 2004 Dec;62(12):2296-300. Japanese.

PMID:
15597799
[PubMed - indexed for MEDLINE]
5.

Protective mechanisms of activated protein C in severe inflammatory disorders.

Neyrinck AP, Liu KD, Howard JP, Matthay MA.

Br J Pharmacol. 2009 Oct;158(4):1034-47. doi: 10.1111/j.1476-5381.2009.00251.x. Epub 2009 May 14. Review.

PMID:
19466992
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.

Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL; International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine.

Crit Care Med. 2008 Jan;36(1):296-327. Erratum in: Crit Care Med. 2008 Apr;36(4):1394-6.

PMID:
18158437
[PubMed - indexed for MEDLINE]
7.

Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients.

Martí-Carvajal AJ, Solà I, Gluud C, Lathyris D, Cardona AF.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD004388. doi: 10.1002/14651858.CD004388.pub6. Review.

PMID:
23235609
[PubMed - indexed for MEDLINE]
8.

Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation.

Esmon CT.

Crit Care Med. 2001 Jul;29(7 Suppl):S48-51; discussion 51-2. Review.

PMID:
11445734
[PubMed - indexed for MEDLINE]
9.

Lack of evidence for qualitative treatment by disease severity interactions in clinical studies of severe sepsis.

Macias WL, Nelson DR, Williams M, Garg R, Janes J, Sashegyi A.

Crit Care. 2005;9(6):R607-22. Epub 2005 Sep 22. Review.

PMID:
16280057
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Inflammation and coagulation: implications for the septic patient.

Dellinger RP.

Clin Infect Dis. 2003 May 15;36(10):1259-65. Epub 2003 May 8. Review.

PMID:
12746771
[PubMed - indexed for MEDLINE]
Free Article
11.

Activated protein C attenuates pulmonary coagulopathy in patients with acute respiratory distress syndrome.

Cornet AD, Hofstra JJ, Vlaar AP, Tuinman PR, Levi M, Girbes AR, Schultz MJ, Groeneveld AB, Beishuizen A.

J Thromb Haemost. 2013 May;11(5):894-901. doi: 10.1111/jth.12179.

PMID:
23433188
[PubMed - indexed for MEDLINE]
12.

[Role of coagulation in acute pulmonary lesion physiopathology. Parallelism with sepsis].

Ferrer R, Navas A, Adda M, Artigas A.

Med Intensiva. 2008 Aug-Sep;32(6):304-11. Spanish.

PMID:
18601838
[PubMed - indexed for MEDLINE]
Free Article
13.

Drotrecogin alfa (activated) (recombinant human activated protein C) for the treatment of severe sepsis.

Bernard GR.

Crit Care Med. 2003 Jan;31(1 Suppl):S85-93. Review.

PMID:
12544981
[PubMed - indexed for MEDLINE]
14.

The role of heparin and allied compounds in the treatment of sepsis.

Cornet AD, Smit EG, Beishuizen A, Groeneveld AB.

Thromb Haemost. 2007 Sep;98(3):579-86. Review.

PMID:
17849046
[PubMed - indexed for MEDLINE]
15.

Activated protein C in sepsis: emerging insights regarding its mechanism of action and clinical effectiveness.

Haley M, Cui X, Minneci PC, Deans KJ, Natanson C, Eichacker PQ.

Curr Opin Infect Dis. 2004 Jun;17(3):205-11. Review.

PMID:
15166822
[PubMed - indexed for MEDLINE]
16.

The current management of septic shock.

Russel JA.

Minerva Med. 2008 Oct;99(5):431-58. Review.

PMID:
18971911
[PubMed - indexed for MEDLINE]
17.

[Should patients with severe sepsis be treated with activated protein C?].

Laake JH, Bergmann JB, Riddervold F, Bjørneklett A, Aukrust P, Frøland SS.

Tidsskr Nor Laegeforen. 2004 Mar 18;124(6):782-4. Review. Norwegian.

PMID:
15039808
[PubMed - indexed for MEDLINE]
Free Article
18.

Pharmacology, clinical efficacy, and safety of drotrecogin alfa (activated).

Rudis MI, Fish DN.

Pharmacotherapy. 2002 Dec;22(12 Pt 2):182S-195S. Review.

PMID:
12492225
[PubMed - indexed for MEDLINE]
19.

Benefit-risk assessment of drotrecogin alfa (activated) in the treatment of sepsis.

De Backer D.

Drug Saf. 2007;30(11):995-1010. Review.

PMID:
17973539
[PubMed - indexed for MEDLINE]
20.

[Activated protein C, coagulation, inflammation, and treatment of severe sepsis].

van Deventer SJ, Pajkrt D.

Ned Tijdschr Geneeskd. 2001 Mar 31;145(13):613-6. Review. Dutch.

PMID:
11305209
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk